Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP)

被引：11
作者：
Ronaghy, Arash [1 ]
Streilein, Robert D. [1 ]
Hall, Russell P., III [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27710 USA
来源：
JOURNAL OF DERMATOLOGICAL SCIENCE | 2014年 / 74卷 / 01期
关键词：
Bullous pemphigoid; Auto-antibodies: IgG subclass; Rituximab; BP180; ECTODOMAIN;
D O I：
10.1016/j.jdermsci.2013.11.014
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：93 / 94
页数：2
相关论文
共 10 条
[1]  
GIUDICE GJ, 1993, J IMMUNOL, V151, P5742
[2]  
Hall RP, 2013, J INVEST DERMATOL
[3]   Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain [J].
Hofmann, S ;
Thomas-Uszynski, S ;
Hunziker, T ;
Bernard, P ;
Koebnick, C ;
Stauber, A ;
Schuler, G ;
Borradori, L ;
Hertl, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) :1065-1073
[4]   A single cycle of rituximab for the treatment of severe pemphigus [J].
Joly, Pascal ;
Mouquet, Hugo ;
Roujeau, Jean-Claude ;
D'Incan, Michel ;
Gilbert, Daniele ;
Jacquot, Serge ;
Gougeon, Marie-Lise ;
Bedane, Christophe ;
Muller, Ralf ;
Dreno, Brigitte ;
Doutre, Marie-Sylvie ;
Delaporte, Emmanuel ;
Pauwels, Christine ;
Franck, Nathalie ;
Caux, Frederic ;
Picard, Catherine ;
Tancrede-Bohin, Emmanuelle ;
Bernard, Philippe ;
Tron, Francois ;
Hertl, Michael ;
Musette, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (06) :545-552
[5]   Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients [J].
Kasperkiewicz, Michael ;
Shimanovich, Iakov ;
Ludwig, Ralf J. ;
Rose, Christian ;
Zillikens, Detlef ;
Schmidt, Enno .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (03) :552-558
[6]   Rituximab for the Treatment of IgG4-Related Disease Lessons From 10 Consecutive Patients [J].
Khosroshahi, Arezou ;
Carruthers, Mollie N. ;
Deshpande, Vikram ;
Unizony, Sebastian ;
Bloch, Donald B. ;
Stone, John H. .
MEDICINE, 2012, 91 (01) :57-66
[7]   Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the TgG1 and IgG4 subclasses [J].
Laffitte, E ;
Skaria, M ;
Jaunin, F ;
Tamm, K ;
Saurat, JH ;
Favre, B ;
Borradori, L .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) :760-768
[8]   Rituximab in autoimmune bullous diseases:: mixed responses and adverse effects [J].
Schmidt, E. ;
Seitz, C. S. ;
Benoit, S. ;
Broecker, E. B. ;
Goebeler, M. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) :352-356
[9]   Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid [J].
Schmidt, E ;
Obe, K ;
Bröcker, EB ;
Zillikens, D .
ARCHIVES OF DERMATOLOGY, 2000, 136 (02) :174-178
[10]   A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid [J].
Zillikens, D ;
Mascaro, JM ;
Rose, PA ;
Liu, Z ;
Ewing, SM ;
Caux, F ;
Hoffmann, RG ;
Diaz, LA ;
Giudice, GJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (05) :679-683
1